Cambridge Nutritional Sciences plc (AIM:CNSL)
1.510
-0.040 (-2.58%)
Oct 9, 2026, 3:41 PM GMT
AIM:CNSL Revenue
In the fiscal year ending March 31, 2026, Cambridge Nutritional Sciences had annual revenue of 6.98M GBP, down -16.27%. Cambridge Nutritional Sciences had revenue of 3.11M in the half year ending March 31, 2026. That makes Cambridge Nutritional Sciences the 37,672nd largest company in the world by revenue and 736th in the United Kingdom.
Revenue
6.98M
Revenue Growth
-16.27%
P/S Ratio
0.53
Revenue / Employee
82.06K
Employees
85
Market Cap
3.69M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 6.98M | -1.36M | -16.27% |
| Mar 31, 2025 | 8.33M | -1.44M | -14.77% |
| Mar 31, 2024 | 9.77M | 2.23M | 29.53% |
| Mar 31, 2023 | 7.55M | -993.00K | -11.63% |
| Mar 31, 2022 | 8.54M | 1.72M | 25.28% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 46.25B |
| GSK plc | 33.20B |
| Haleon | 11.15B |
| Smith & Nephew | 4.77B |
| Surgical Innovations Group | 11.48M |
| Proteome Sciences | 3.77M |
| GENinCode | 2.60M |
| Futura Medical | 2.32M |